Cyfuse Biomedical K.K.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. (株式会社サイフューズ, 4892), Pharmaceutical. A board of 8 and 10 largest shareholders, as filed on EDINET for the year to December 2025. EDINET filing S100XV4M, filed 2026-03-27. Source: company filings on EDINET (Financial Services Agency of Japan).
Financial summary
| Fiscal year end | Revenue (¥bn) | Profit (¥bn) | Total assets (¥bn) | EPS (¥) | DPS (¥) | Employees |
|---|---|---|---|---|---|---|
| 2021-12-31 | 0.7 | 0.1 | 2.6 | 285.53 | — | 22 |
| 2022-12-31 | 0.4 | −0.5 | 4.8 | −177.67 | — | 21 |
| 2023-12-31 | 0.1 | −0.6 | 4.2 | −75.42 | — | 21 |
| 2024-12-31 | 0.1 | −0.9 | 3.5 | −108.34 | — | 21 |
| 2025-12-31 | 0.2 | −0.8 | 4.3 | −86.78 | — | 23 |
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown